ABSTRACT
Introduction Inequitable uptake of routine and COVID-19 vaccinations has been documented among intersectionally marginalised populations, including migrants, and attributed to issues of mistrust, access, and low vaccine confidence. Novel approaches which seek to share power, build trust and co-design tailored interventions with marginalised or underserved communities must be explored, to promote equitable engagement with vaccination and other health interventions.
Methods A theory-informed, qualitative, community-based participatory research study, designed and led by a community-academic partnership, which aimed to understand decision-making related to COVID-19 vaccination among Congolese migrants in the UK and co-design a tailored intervention to strengthen their vaccine uptake (2021-2022). Barriers and facilitators to COVID-19 vaccination, information and communication preferences, and intervention suggestions were explored through qualitative in-depth interviews with Congolese migrants, thematically analysed, and mapped to the theoretical domains framework (TDF) and the Capability, Opportunity, Motivation, Behaviour (COM-B) model to identify target behaviours and strategies to include in interventions. Workshops were done in partnership with Congolese migrants to co-design and tailor interventions.
Results 32 Congolese adult migrants (foreign-born and living in UK; 24 (75%) women, mean 14.3 [SD 7.5] years in UK, mean age 52.6 [SD 11.0] years) took part in in-depth interviews and 16 (same sample) took part in co-design workshops. We identified 14 barriers and 10 facilitators to COVID-19 vaccination; most barrier data related to four TDF domains (beliefs about consequences; emotion; social influences; environmental context and resources), and the behavioural diagnosis concluded interventions should target improving psychological capability, reflective and automatic motivations, and social opportunities. Strategies included behaviour change techniques based on education, persuasion, modelling, enablement, and environmental restructuring, which resulted in a co-designed intervention comprising community-led workshops, COVID-19 vaccination plays and posters. Findings and interventions were disseminated through a community celebration event.
Conclusions Our study demonstrates how behavioural theory can be applied to co-designing tailored interventions with marginalised migrant communities through a participatory research paradigm to address a range of health issues and inequalities. Future research should build on this empowering approach, with the goal of developing more sensitive vaccination services and interventions which respond to migrant communities’ unique cultural needs and realities.
Patient or public contribution Patient and public involvement (PPI) were embedded in the participatory study design and approach. An independent PPI board comprising five adult migrants with lived experience of accessing healthcare in the UK were also consulted at significant points over the course of the study.
Practitioner points
Research has shown that migrants experience a range of health and vaccination inequalities but are not well included in health research nor the design of interventions to address these. Using community-based participatory methods, we demonstrated that underserved communities, such as migrants, are resilient, resourceful, and use community assets to find real-world solutions to their health needs.
Our approach shows how practitioners can adapt and use behavioural theory and design thinking within a participatory research paradigm to meaningfully involve underserved populations in co-designing acceptable and culturally relevant health interventions to address a range of health issues and inequalities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the National Institute for Health and Care Research (NIHR) and seed funding from St Georges University of London Public Engagement Network. SH and AFC are additionally funded by the Academy of Medical Sciences (SBF005\1111), the NIHR (NIHR Advanced Fellowship 300072) and the World Health Organization. SH acknowledges funding from the Novo Nordisk Foundation/La Caixa Foundation (Mobility Global Medicine and Health Research grant). AD is funded by the Medical Research Council (MRC) (MR/N013638/1). The funders did not have any direct role in the writing or decision to submit this manuscript for publication. The views expressed are those of the author(s) and not necessarily those of the NHS or the NIHR. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Research Ethics Committee of St George's University of London gave ethical approval for this work (REC reference 2021.0128).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* First author
acrawsha{at}sgul.ac.uk, hcwsg{at}outlook.com, hcwsg{at}outlook.com, hcwsg{at}outlook.com, caroline{at}hcvs.org.uk, adeal{at}sgul.ac.uk, carterj{at}sgul.ac.uk, fknights{at}sgul.ac.uk, t.vandrevala{at}kingston.ac.uk, alice.forman{at}ourfuturehealth.org.uk, s.hargreaves{at}sgul.ac.uk
Data Availability
All data produced in the present study are available upon reasonable request to the authors.